1 |
Kim NH, Chung JH, Park RH, Park JB. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005;115:919-930
DOI
ScienceOn
|
2 |
Adams WM. Bilateral hypertrophy of the masseter muscle: an operation for correction. Br J Plast Surg 1949;2:78
|
3 |
Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 1994;32:25-28
|
4 |
von Lindern JJ, Niederhagen B, Appel T, Bergé S, Reich RH. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 2001;107:327-332
DOI
ScienceOn
|
5 |
Tan EK, Jankovic J. Treating severe bruxism with botul-inum toxin. JADA 2000;131: 211-216
|
6 |
Rivera-Morales WC, McCall WD Jr. Reliability of a portable electromyographic unit to measure bruxism. J Prosthet Dent 1995;73:184-189
DOI
ScienceOn
|
7 |
Prabhu NT, Munshi AK. Measurement of masseter and temporalis muscle thickness using ultrasonographic technique. J Clin Pediatr Dent 1994;19: 41-44
|
8 |
Choe SW, Cho WI, Lee CK, Seo SJ. Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg 2005;31:502-508
DOI
ScienceOn
|
9 |
Seligman DA, Pullinger AG, Solberg WK. The prevalence of dental attrition and its association with factors of age, gender, occlusion and TMJ symptomatology. J Dent Res 1988;67:1323-1333
DOI
ScienceOn
|
10 |
Gurney CE. Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 1947;73:137-139
DOI
ScienceOn
|
11 |
Maxwell JH, Waggoner RW. Hypertrophy of the masseter muscles. Ann Otol Rhinol Laryngol 1946;43:593
|
12 |
Wood GD. Masseteric hypertrophy and its surgical correction. Br Dent J 1982;152:416 -417
DOI
ScienceOn
|
13 |
Botulinum toxin. Lancet (editorial) 1992;340:1508-1509
DOI
|
14 |
Jang HY, Kang SC, Kim ST, Kim CY, Choi JH. Effect of botulinum toxin type A and occlusal splint on masseter muscle evaluated with computed tomographic measurement. Korean J Oral Med 2005;30:247-255
|
15 |
Marbach JJ, Raphael KG, Janal MN, Hirschkorn-Roth R. Reliability of clinician judgments of bruxism. J Oral Rehabil 2003;30:113-118
DOI
ScienceOn
|
16 |
Bechers HL. Masseteric muscle hypertrophy and intra-oral surgical correction. J Maxillofac Surg 1977;5:28
|
17 |
To EWH, Ahuja AT, Ho WS et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertro-phy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200
DOI
ScienceOn
|
18 |
Mandel L, Tharakan M. Treatment of unilateral masset-eric hypertrophy with botulinum toxin: case report. J Oral Maxillofac Surg 1999;57:1017-1019
DOI
|
19 |
Van Jandijcke M, Marchau MM. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990;53:530
|
20 |
Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 1994;32:29-33
DOI
ScienceOn
|
21 |
Bowley JF, Stockstill JW, Pierece CJ. Reliability and validity of instrumentational used to record nocturnal clenching and/or grinding. J Orofac Pain 1993;7:378-385
|
22 |
Legg JW. Enlargement of the temporal and masseter muscles on both sides. Trans Pathol Soc Lond 1880;31:361-366
|
23 |
Kim HS, Kim KS, Kim ST, Choi JH. Influence of botulinum toxin A injection on the electromyographic activity of masseter muscle. Korean J Oral Med 2004;29:435-444
|
24 |
Raadsheer MC, Van Eijden TMGJ, Van Spronsen PH et al. A comparison of human masseter muscle thickness measured by ultrasonography and magnetic resonance imaging. Archs Oral Biol 1994;39: 1079-1084
DOI
ScienceOn
|
25 |
Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324: 1186-1194
DOI
ScienceOn
|
26 |
Gallo LM, Lavigne G, Rompre P, Palla S. Reliabililty of scoring EMG orofacial events: polysomnography compared with ambulatory recordings. Journal of Sleep Research 1997; 6:259-263
DOI
ScienceOn
|